GlaxoSmithKline has beaten analyst expectations by increasing its sales 19pc in the first quarter under new boss Emma Walmsley. Sales at the pharmaceutical giant hit £7.4bn in the three months to March 31, up from £6.2bn a year previously and higher than the £7.25bn pencilled in by analysts. But what about the pharmaceutical industry worldwide?
